JAL

JAL Therapeutics is a preclinical stage life sciences company, focused on drug development for the treatment of Alzheimer's disease and other chronic conditions... JAL's unique approach centers on a mechanism of action that's designed to activate the cholinergic anti-inflammatory pathway and treat both the symptoms of AD, as well as prevent the neurotoxic cascading pathogenesis of the disease. Our platform may modify the effects of chronic and genetic risk factors that mediate the onset of AD. Two successful rounds of animal testing have validated JAL-001 as having high potential as a treatment for AD and other chronic diseases.​

Also known as: JAL Therapeutics

Primary location: Irvine United States